Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN1367253A reveals microbial enzyme method for high-purity D-panthenol. Offers cost reduction and supply chain reliability for vitamin manufacturers.
Novel synthesis route for high-purity ursolic acid derivatives offering cost reduction and scalable supply chain solutions for pharmaceutical manufacturing.
Novel Ag-catalyzed trifluoromethylation of amides reduces cost and complexity versus traditional AgF methods. Scalable API intermediate production with mild conditions.
Novel patent CN105985317B details a metal-free Ceritinib route enhancing yield and supply chain reliability for pharmaceutical manufacturing.
Discover a novel synthetic route for ursodesoxycholic acid from chenodeoxycholic acid featuring high optical purity and mild conditions for reliable pharmaceutical intermediate supply.
Patent CN104817605B reveals novel synthesis route offering supply chain stability and cost efficiency for high-purity pharmaceutical intermediate manufacturing.
Novel 3-step chiral synthesis of PE phospholipid intermediate. High yield, mild conditions, scalable process for drug delivery systems.
Patent CN113493814B reveals a one-step enzymatic synthesis of DHEA from androstenedione ester, achieving 94% yield without unstable intermediates.
Patent CN115304524A details a metal-free route to beta-acyl allyl methyl sulfones using DMSO. This method offers significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN112481224A discloses a robust Baeyer-Villiger monooxygenase for synthesizing high-purity S-benzyl sulfoxide and epsilon-caprolactone with superior stereoselectivity and industrial scalability.
Discover a robust synthesis method for Procaterol Hydrochloride intermediates. Enhanced stability, high purity, and scalable manufacturing for pharmaceutical supply chains.
Novel hydrogenation process for Obeticholic Acid Type 1 reduces steps and improves purity. Ensures stable supply chain and cost efficiency for global pharmaceutical manufacturing partners.
Patent CN104860915B reveals water-based synthesis for 4H-4-arylbenzopyran intermediates. Achieve high purity and cost reduction in pharmaceutical manufacturing with scalable green chemistry.
Novel azide-free synthesis route for Oseltamivir phosphate ensuring safety and scalability for global pharmaceutical supply chains.
Novel azide-free route for cephalosporin intermediates. High purity scalable process reduces supply chain risks for pharmaceutical manufacturing partners globally.
Patent CN115197058A reveals a novel total synthesis of anticancer Dysideanone B. Discover cost-effective manufacturing routes and supply chain advantages for pharmaceutical intermediates.
Novel continuous flow quaternization technology ensures high purity cyclic ammonium salts. Reduces reaction time significantly compared to batch methods for reliable supply.
Novel method for anti-tumor trans-stilbene compounds avoiding cis-isomers. High yield, scalable process for pharmaceutical intermediates.
Novel bio-chemical route for phenylephrine ensures high purity and cost efficiency for pharmaceutical supply chains globally via patented enzymatic reduction.
Patent CN101993420A reveals a high-yield route for HIV drug intermediates, offering cost reduction and scalable manufacturing for global pharma supply chains.